Kestra Medical Technologies, Ltd.
NMS: KMTSLive Quote
📈 ZcoreAI Score
Our AI model analyzes Kestra Medical Technologies, Ltd.'s price action across multiple timeframes using regression channels and statistical scoring.
Get KMTS Z-Score →About Kestra Medical Technologies, Ltd.
Healthcare
Medical Instruments & Supplies
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
📊 Fundamental Analysis
Kestra Medical Technologies, Ltd. demonstrates a profit margin of -173.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 62.7% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -92.7%, which indicates that capital utilization is currently under pressure.
At a current price of $17.87, KMTS currently sits at the 28th percentile of its 52-week range (Range: $13.25 - $30.00).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
Key Financials
Market Cap
$1.04B
Trailing P/E
--
Forward P/E
-8.35
Beta (5Y)
--
52W High
$30.00
52W Low
$13.25
Avg Volume
352K
Day High
Day Low